Blogs

Pathology in life sciences research and development (R&D) can be heavy on collaboration. That’s a good thing – because science is a team effort. But as you engage more stakeholders, lab professionals, outside partners, and compliance...

FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...

CYPATH is the second largest independent pathology group in France, with nine technical laboratories in the east part of the country. The private group analyzes over 800,000 cases per year with a specialization in histopathology, cytopathology,...

While many people worry that Artificial Intelligence might take away crucial jobs, it’s worth considering how the technology could revamp healthcare—particularly around detection of breast cancer, which affects millions of women around the...

Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...